Management and Role of Pharmacist in Chronic Heart Failure

Mohamed Ashraf; Radhika Venugopal

doi:10.46624/ajptr.2019.v9.i1.018

February 8, 2019American Journal of PharmTech ResearchOpen Access

Management and Role of Pharmacist in Chronic Heart Failure

View Full Paper

Ask AI

Bookmark

Share

Structured PICO

P

Population

Patients with chronic heart failure, including heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

I

Intervention

Guideline directed medical therapy including ACE inhibitors, ARBs, beta-blockers, loop diuretics, hydralazine/nitrates, aldosterone antagonists, and digoxin.

Implication

A narrative review outlining the standard guideline-directed medical therapies for chronic heart failure.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ashraf et al. (2019) studied this question.

synapsesocial.com/papers/6a71898826a7f98052ddd7bb https://doi.org/10.46624/ajptr.2019.v9.i1.018

View Full Paper

Ask AI

Bookmark

Share

Management and Role of Pharmacist in Chronic Heart Failure

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Management and Role of Pharmacist in Chronic Heart Failure

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from American Journal of PharmTech Research

Keep reading

More related papers

More from American Journal of PharmTech Research